Dermata Therapeutics Stock (NASDAQ: DRMAW) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 17.33K |
Day Range | - - - |
52 Wk Range | 0.01 - 0.03 |
Market Cap | - |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 0 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMAW) through any online brokerage.
Other companies in Dermata Therapeutics’s space includes: Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX) and Roivant Sciences (NASDAQ:ROIV).
There is no analysis for Dermata Therapeutics to provide a consensus price target.
The stock price for Dermata Therapeutics (NASDAQ: DRMAW) is $0.0171 last updated August 1, 2024 at 4:03 PM EDT.
There are no upcoming dividends for Dermata Therapeutics.
Dermata Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Dermata Therapeutics.
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.